For: | Chen XL, Su BS, Sun RQ, Zhang J, Wang YL. Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma. World J Gastroenterol 2005; 11(8): 1228-1231 [PMID: 15754411 DOI: 10.3748/wjg.v11.i8.1228] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i8/1228.htm |
Number | Citing Articles |
1 |
Nora Manoukian Forones, Kharen Yaemi Kawamura, Helena Regina Comodo Segreto, Ricardo Artigiani Neto, Gustavo Rubino de Azevedo Focchi, Celina Tizuko Fujiyama Oshima. Expression of COX-2 in Stomach Carcinogenesis. Journal of Gastrointestinal Cancer 2008; 39(1-4) doi: 10.1007/s12029-008-9039-6
|
2 |
Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs. Cells 2019; 8(7): 726 doi: 10.3390/cells8070726
|
3 |
Xiao-Wei Zhang, Jun Li, Yu-Xing Jiang, Yu-Xiang Chen. Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis. World Journal of Gastroenterology 2017; 23(12): 2234-2245 doi: 10.3748/wjg.v23.i12.2234
|
4 |
Weiwei Hu, Lei Fang, Wuyang Hua, Shaohua Gou. Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance. Journal of Inorganic Biochemistry 2017; 175: 47 doi: 10.1016/j.jinorgbio.2017.07.002
|
5 |
L.W.C. Chow, W.T.Y. Loo, M. Toi. Current directions for COX-2 inhibition in breast cancer. Biomedicine & Pharmacotherapy 2005; 59: S281 doi: 10.1016/S0753-3322(05)80046-0
|
6 |
Kun Peng, Bing-Bing Liang, Wenting Liu, Zong-Wan Mao. What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives. Coordination Chemistry Reviews 2021; 449: 214210 doi: 10.1016/j.ccr.2021.214210
|
7 |
Carina Pereira, Hugo Sousa, Paula Ferreira, Maria Fragoso, Luís Moreira-Dias, Carlos Lopes, Rui Medeiros, Mário Dinis-Ribeiro. -765G > C <i>COX-2</i> polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia. World Journal of Gastroenterology 2006; 12(34): 5473-5478 doi: 10.3748/wjg.v12.i34.5473
|
8 |
Smita Kumari, Sudhanshu Sharma, Dia Advani, Akanksha Khosla, Pravir Kumar, Rashmi K. Ambasta. Unboxing the molecular modalities of mutagens in cancer. Environmental Science and Pollution Research 2022; 29(41): 62111 doi: 10.1007/s11356-021-16726-w
|
9 |
Julie L Ryan, Richard J Jones, Shannon C Kenney, Ashley G Rivenbark, Weihua Tang, Elizabeth RW Knight, William B Coleman, Margaret L Gulley. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infectious Agents and Cancer 2010; 5(1) doi: 10.1186/1750-9378-5-27
|
10 |
Aitor Benedicto, Joana Marquez, Alba Herrero, Elvira Olaso, Elzbieta Kolaczkowska, Beatriz Arteta. Decreased expression of the β2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3823-2
|
11 |
Shimin Chen, Lu Chen, Yuling Tan, Jiehong Wang. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility. Medicine 2019; 98(18): e15468 doi: 10.1097/MD.0000000000015468
|
12 |
Paramesh Jangili, Miae Won, Seo Jin Kim, Jieun Chun, Inseob Shim, Chulhun Kang, Wen Xiu Ren, Jong Seung Kim. Binary Drug Reinforced First Small-Molecule-Based Prodrug for Synergistic Anticancer Effects. ACS Applied Bio Materials 2019; 2(8): 3532 doi: 10.1021/acsabm.9b00418
|
13 |
Masoud Mireskandari, Ali Fakhr Shafaii, Gian Kayser, Klaus Kayser. Lack of CD117 and rare bcl-2 expression in stomach cancer by immunohistochemistry. An immunohistochemical study with review of the literature. Diagnostic Pathology 2006; 1(1) doi: 10.1186/1746-1596-1-7
|
14 |
Masakazu Yashiro, Kazunori Nakazawa, Masashige Tendo, Kinshi Kosaka, Osamu Shinto, Kosei Hirakawa. Selective cyclooxygenase‐2 inhibitor downregulates the paracrine epithelial–mesenchymal interactions of growth in scirrhous gastric carcinoma. International Journal of Cancer 2007; 120(3): 686 doi: 10.1002/ijc.22329
|
15 |
F.P. Martins, R. Artigiani Neto, C.T. Oshima, P.P. da Costa, N.M. Forones, A.P. Ferrari. Over-expression of cyclooxygenase-2 in endoscopic biopsies of ectopic gastric mucosa. Brazilian Journal of Medical and Biological Research 2007; 40(11): 1447 doi: 10.1590/S0100-879X2007001100005
|
16 |
Jin Ho Choi, Woo Hyun Paik, Min Su You, Kyong Joo Lee, Young Hoon Choi, Bang-sup Shin, Sang Hyub Lee, Ji Kon Ryu, Yong-Tae Kim. Aspirin for metal stent in malignant distal common bile duct obstruction (AIMS): study protocol for a multicenter randomized controlled trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-4083-z
|
17 |
MING LI, SHI-YUN TAN, XIAO-FAN WANG. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE2 synthesis and COX-2 expression. Oncology Reports 2014; 32(6): 2845 doi: 10.3892/or.2014.3543
|
18 |
Kai Wu, Liu Yang, Cong Li, Chao-Hui Zhu, Xin Wang, Yi Yao, Yu-Jie Jia. MicroRNA-146a Enhances Helicobacter pylori Induced Cell Apoptosis in Human Gastric Cancer Epithelial Cells. Asian Pacific Journal of Cancer Prevention 2014; 15(14): 5583 doi: 10.7314/APJCP.2014.15.14.5583
|
19 |
Weigang Duan, Luyong Zhang. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2006; 74(5): 317 doi: 10.1016/j.plefa.2006.02.006
|
20 |
S. Redondo, E. Ruiz, A. Gordillo-Moscoso, J. Navarro-Dorado, M. Ramajo, E. Rodríguez, F. Reguillo, M. Carnero, M. Casado, T. Tejerina. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis. Diabetologia 2011; 54(1): 190 doi: 10.1007/s00125-010-1947-x
|